According to FutureWise analysis the market In Vivo Imaging Systems in 2023 is US$ 55.13 million, and is expected to reach US$ 72.15 million by 2031 at a CAGR of 3.42%.
In vivo imaging systems are divided into in vivo, which means performed inside a living organism, and imaging systems, or visual representations. This technique is used for biological imaging in order to study cellular activity and the effects of drugs in various diseases. System types include morphological imaging systems and molecular imaging systems. High-frequency micro-ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI) form morphological imaging systems, whereas fluorescence, bioluminescence, single photon emission computed tomography (SPECT), and positron emission tomography (PET) constitute molecular imaging systems. In vivo imaging systems can either be used for animals or humans, depending on the use. It's typical for in vivo imaging systems to be used in research laboratories to study the activities of drugs on animals like albino mice and albino rats. Small animals are scanned with both a full body scan and a targeted scan. Full body scanning is a popular imaging method because it is economic and can be used for commercialization and routine validation of new drugs. Small animal In vivo imaging includes the measurement and classification of molecular-level biological processes that are used to study specific drug targets. A small animal's in vivo imaging consists of micro MRI, micro CT, micro PET, micro SPECT, digital angiography, x-ray imaging, and magnetic particle imaging.
FutureWise Market Research has instantiated a report that provides an intricate analysis of In Vivo Imaging Systems Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the In Vivo Imaging Systems Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.